| Financial Year |
March 31 2023 |
| Monetary Funds |
2,363,579,539.00 |
| Held-for-trading Financial Assets |
3,000,000.00 |
| Notes Receivable |
127,201,483.00 |
| Accounts Receivable |
1,841,410,929.00 |
| Advances to Suppliers |
344,384,749.00 |
| Other Receivables |
149,792,355.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,152,947,981.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,997,633.00 |
| Other Current Assets |
136,457,905.00 |
| Total Current Assets |
9,150,790,598.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
78,079,823.00 |
| Long-term Equity Investment |
66,204,580.00 |
| Investment Properties |
332,533,443.00 |
| Fixed Assetes |
1,092,997,366.00 |
| Under-construction Projects |
228,935,957.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
590,213,462.00 |
| R&D expenses |
-- |
| Goodwill |
5,499,947,619.00 |
| Long-Term Deferred and Prepaid Expenses |
696,650,412.00 |
| Deferred Income Tax Assets |
76,100,200.00 |
| Other Non-Current Assets |
79,889,430.00 |
| Sub-Total of Non-Current Assets |
12,142,958,622.00 |
| Total Assets |
21,293,749,220.00 |
| Short-Term Loans |
569,682,293.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,193,405,171.00 |
| Accounts Payable |
2,763,056,894.00 |
| Accounts Received In Advance |
14,163,183.00 |
| Employee Compensation Payable |
406,110,545.00 |
| Taxes Payable |
209,620,410.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
743,394,092.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,570,230,266.00 |
| Other Current Liabilities |
16,627,009.00 |
| Sub-Total of Current Liabilities |
10,721,083,037.00 |
| Long-term Loans |
1,572,656,018.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,827,850.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,240,278,055.00 |
| Total Liabilities |
13,961,361,092.00 |
| Paid-In Capital(Or Share Stock) |
584,902,902.00 |
| Capital Surplus |
2,641,094,301.00 |
| Surplus Reserve |
218,098,199.00 |
| LESS:Treasury Stock |
42,929,952.00 |
| Undistributed Profits |
3,313,886,568.00 |
| Minority Stockholder's Interest |
584,800,279.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,747,587,849.00 |
| Owner's Equity（Stockholder's Equity） |
7,332,388,128.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,293,749,220.00 |
